Inspire Medical Systems
INSP
143 hedge funds and large institutions have $1.01B invested in Inspire Medical Systems in 2019 Q1 according to their latest regulatory filings, with 51 funds opening new positions, 60 increasing their positions, 23 reducing their positions, and 11 closing their positions.
364% more first-time investments, than exits
New positions opened: 51 | Existing positions closed: 11
161% more repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 23
61% more capital invested
Capital invested by funds: $628M → $1.01B (+$383M)
39% more funds holding
Funds holding: 103 → 143 (+40)
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
10.94% more ownership
Funds ownership: 64.98% → 75.92% (+11%)
44% less call options, than puts
Call options by funds: $2.12M | Put options by funds: $3.8M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$49M |
| 2 |
William Blair Investment Management
Chicago,
Illinois
|
+$47.8M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$13.9M |
| 4 |
O
OppenheimerFunds
New York
|
+$13.6M |
| 5 |
D.E. Shaw & Co
New York
|
+$12.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KXA
KPCB XII Associates
Menlo Park,
California
|
-$73.5M |
| 2 |
O
OrbiMed
New York
|
-$19.4M |
| 3 |
DM
Deerfield Management
New York
|
-$14.1M |
| 4 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$4.31M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$3.73M |
INSP Hedge Fund Activity: Q1 2019 in Review
143 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Inspire Medical Systems (INSP) for Q1 2019, worth a combined $1.01B — up 61% from $628M a quarter earlier.
Buyers outnumbered sellers: 51 funds opened new INSP positions and 11 closed out — a net gain of 40 holders — while 60 added to existing stakes and 23 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $49M. The largest seller was KPCB XII Associates, cutting an estimated $73.5M.
- 143 institutional investors held Inspire Medical Systems (INSP) as of Q1 2019, up from 103 in Q4 2018.
- Funds reported $1.01B of Inspire Medical Systems stock for Q1 2019, up 61% quarter-over-quarter.
- 51 funds opened new Inspire Medical Systems positions in Q1 2019 and 11 closed out, a net change of +40 holders.
- The largest Inspire Medical Systems buyer in Q1 2019 was Morgan Stanley, an estimated $49M added.
- The largest Inspire Medical Systems seller in Q1 2019 was KPCB XII Associates, an estimated $73.5M sold.
Based on aggregated 13F filings for Q1 2019.